Immune checkpoint blockade for the treatment of human hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint blockade for the treatment of human hepatocellular carcinoma

Published:2018-06-06 Issue:8 Volume:48 Page:622-634
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Nishida Naoshi¹,Kudo Masatoshi¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Kindai University Faculty of Medicine; Osaka-Sayama Japan

Funder

Grant-in-Aid for Scientific Research

the Smoking Research Foundation

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.13191/fullpdf

Reference64 articles.

1. JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the Liver Cancer Study Group of Japan;Kudo;Liver Cancer.,2014

2. Hepatocellular carcinoma: therapeutic guidelines and medical treatment;Kudo;Liver Cancer.,2016

3. Molecular targeted agents for hepatocellular carcinoma: current status and future perspectives;Kudo;Liver Cancer.,2017

4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017

5. A new era of systemic therapy for hepatocellular carcinoma with regorafenib and lenvatinib;Kudo;Liver Cancer,2017

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma;Discover Oncology;2024-03-11

2. Immunotherapy in hepatocellular carcinoma: an overview of immune checkpoint inhibitors, drug resistance, and adverse effects;Oncologie;2024-01-01

3. Blockade of PD‐1 and CTLA‐4: A potent immunotherapeutic approach for hepatocellular carcinoma;BioFactors;2023-11-03

4. Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinoma;Frontiers in Immunology;2023-10-25

5. Hepatocellular carcinoma (HCC) immunotherapy by anti-PD-1 monoclonal antibodies: A rapidly evolving strategy;Pathology - Research and Practice;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3